Captopril and nifedipine interactions in the treatment of essential hypertensives: A crossover study

Journal of Hypertension

Volumn 5, Issue , 1987, Pages S139-S142

  Salvetti, Antonio ^a   Innocenti, Pier F ^b   lardella, Manrico ^b   Pambianco, Franco ^b   Saba, Gian C ^c   Rossett, Maurizio ^c   Botta, Gian F ^d  

^a UNIVERSITY OF PISA   (Italy)

^b Ospedale Civico di Carrara   (Italy)

^c USL   (Italy)

^d Medical Department   (Italy)

Author keywords

Blood pressure; Captopril nifedipine interactions; Side effects

Indexed keywords

CAPTOPRIL; NIFEDIPINE;

ADULT; BLOOD PRESSURE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG THERAPY; FEMALE; HUMAN; HYPERTENSION; MALE; ORAL DRUG ADMINISTRATION;

ADULT; AGED; CAPTOPRIL; CLINICAL TRIALS; COMPARATIVE STUDY; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; FEMALE; HUMAN; HYPERTENSION; MALE; MIDDLE AGE; NIFEDIPINE;

EID: 0023571357     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/00004872-198712004-00023     Document Type: Article

References (18)

1. Stornello M, Di Rao G, lachello M, Pisani R, Scapellato L, Pedrinelli R, Salvetti A: Hemodynamic and humoral interactions between captopril and nifedipine. Hypertension 1983, 5 (suppl 11): 154-156.
2. Donnelly R, Elliott HL, Reid JL: Nicardipine combined with enalapril in patients with essential hypertension. Br J Clin Pharmacol 1986, 22:283s-287s.
3. Brouwer RML, Bolli P, Erne P, Conen D, Kiowski W, Buhler FR: Antihypertensive treatment using calcium antagonists in combination with captopril rather than diuretics. J Cardiovasc Pharmacol 1985, 7 (suppl):S88-S91.
4. Mimran A, Ribstein J: Effect of chronic nifedipine in patients inadequately controlled by a converting enzyme inhibitor and a diuretic. J Cardiovasc Pharmacol 1985, 7 (suppl):S92-S95.
5. Mimran A, Ribstein J: Effect of nifedipine in hypertension not controlled by converting enzyme inhibitor and diuretic. Postgrad Med J 1986, 62 (suppl 1): 135-138.
6. White WB, Viadero JJ, Lane TJ, Podesla S: Effects of combination therapy with captopril and nifedipine in severe or resistant hypertension. Clin Pharmacol Ther 1986, 39:43-48.
7. Guazzi MD, De Cesare N, Galli C, Salvioni A, Tramontana C, Tamborini G, Bartorelli A: Calcium-channel blockade with nifedipine and angiotensin converting-enzyme inhibition with captopril in the therapy of patients with severe primary hypertension. Circulation 1984, 70:279-284.
8. Klein WW, Stuhlinger W, Mahr G: Cross-over comparison between captopril and nifedipine. Postgrad Med J 1986, 62 (suppl 1):108-110.
9. Sassano P, Pedrinelli R, Magagna A, Abdel-Hag B, Salvetti A: Humoral and hemodynamic effects of increasing doses of captopril in patients with essential hypertension. Am J Cardiol 1982, 49:1574-1576.
10. Sorkin EM, Clissold SP, Brogden RN: Nifedipine - a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders. Drugs 1985, 30:182-274.
11. Clough DP, Collins MG, Conway J, Hatton R, Keddie JR: Interaction of angiotensin-converting enzyme inhibitors with the function of the sympathetic nervous system. Am J Cardiol 1982, 49:1410-1412.
12. Murphy MB, Scriven AJ, Brown MJ, Causon R, Dollery CT: The effects of nifedipine and hydralazine induced hypotension on sympathetic activity. Eur J Clin Pharmacol 1982, 23:479-485.
13. Hiramatsu K, Yamagishi F, Kubota T, Yamada T: Acute effects of the calcium antagonist, nifedipine, on blood pressure, pulse rate, and the renin-angiotensin-aldosterone system in patients with essential hypertension. Am Heart J 1982, 104:1346-1350.
14. Buhler FR, Hulthen UL, Kiowski W, Bolli P: Greater antihypertensive efficacy of the calcium channel inhibitor verapamil in older and low renin patients. Clin Sci 1982, 63:439s-444s.
15. Groel JT, Tadros SS, Dreslinski GR, Jenkins J: Long-term antihypertensive therapy with captopril. Hypertension 1983, 5 (suppl lll):145-151.
16. Trost BN, Weidmann P: Effects of nitrendipine and other calcium antagonists on glucose metabolism in man. J Cardiovasc Pharmacol 1984, 6 (suppl):S986-S995.
17. Midtbo K, Hals O, van der Meer J: Verapamil compared with nifedipine in the treatment of essential hypertension. J Cardiovasc Pharmacol 1982, 4 (suppl):S363-S368.
18. Johns DW, Baker KM, Ayers CR, Carey RM, Peach MJ: Dilatation of forearm vasculature following angiotensin converting enzyme inhibition by captopril (SQ 14225) in severe hypertension. Circulation 1979, 60:227-232.